FONAR Corporation

    Jurisdiction
    United States
    ISIN
    US3444374058 (FONR)
    Sectors
    1. Healthcare
    2. Medical - Devices

    Scores

    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    2 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    3 / 7

    Profile

    FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. Read full profile

    Fundamentals

    Net revenue
    €67.56M
    Gross margin
    35.3%
    EBIT
    €9.89M
    EBIT margin
    14.6%
    Net income
    €9.35M
    Net margin
    13.8%

    Statement period: - (published )

    Products

    Product Revenue
    Total €104.35M 154.4%

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    Last dividend amount
    $0.00
    Ex date
    Payment date

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    No insider transactions in the last 90 days. View older insider transactions

    Investor transactions

    Name Shares Value Last change Change type
    Peter Brown 304K $4.26M -9.3K Sell

    Earnings Calls

    Add to watchlist

    Notifications